Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
3-acetylpyridine-deamino-NADH + 2,6-dichlorophenol indophenol
3-acetylpyridine-deamino-NAD+ + reduced 2,6-dichlorophenolindophenol
3-acetylpyridine-NADH + 2,6-dichlorophenolindophenol
3-acetylpyridine-NAD+ + reduced 2,6-dichlorophenolindophenol
deamino-NADH + 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone
?
-
-
-
-
?
deamino-NADH + K3Fe(CN)6
?
-
-
-
-
?
menadione + NADH + H+
menadiol + NAD+
-
menadione is reduced by a two-electron transfer reaction
-
-
?
NADH + 1,2-naphthoquinone
NAD+ + 1,2-naphthoquinol
-
-
-
?
NADH + 1,4-benzoquinone
NAD+ + 1,4-benzoquinol
-
-
?
NADH + 2,3-dimethoxy-5-methyl-1,4-benzoquinone
NAD+ + ?
-
-
-
-
?
NADH + 2,5-dimethoxy-1,4-benzoquinone
NAD+ + 2,5-dimethoxy-1,4-benzoquinol
NADH + 2,5-toluquinone
NAD+ + 2,5-toluquinol
-
-
-
?
NADH + 2,6-dimethoxy-1,4-benzoquinone
NAD+ + 2,6-dimethoxy-1,4-benzoquinol
NADH + 2-methoxy-1,4-benzoquinone
NAD+ + 2-methoxy-1,4-benzoquinol
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
NADH + 4,5-dimethoxy-1,2-benzoquinone
NAD+ + 4,5-dimethoxy-1,2-benzoquinol
4,5-dimethoxy-1,2-benzoquinone produced by Gleophyllum trabeum
-
?
NADH + 5-hydroxy-1,4-naphthoquinone
NAD+ + 5-hydroxy-1,4-naphthoquinol
NADH + benzoquinone
NAD+ + benzoquinol
NADH + duroquinone
NAD+ + duroquinol
NADH + Fe(CN)63-
NAD+ + Fe(CN)64-
-
-
-
-
?
NADH + ferricyanide
NAD+ + H+ + ferrocyanide
-
-
-
?
NADH + ferrocenium hexafluorophosphate
NAD+ + H+ + ferrocene
highest specific activity with NADH and ferrocenium hexafluorophosphate as electron acceptor
-
-
?
NADH + H+ + 1,4-benzoquinone
NAD+ + 1,4-benzoquinol
NADH + H+ + 1,4-naphthoquinone
NAD+ + 1,4-naphthoquinol
NADH + H+ + 2,3-dimethyl naphthoquinone
NAD+ + 2,3-dimethyl naphthoquinol
NADH + H+ + acceptor
NAD+ + reduced acceptor
-
-
-
-
?
NADH + H+ + atovaquone
NAD+ + reduced atovaquone
-
atovaquone is 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione
-
-
?
NADH + H+ + clofazimine
NAD+ + reduced clofazimine
NADH + H+ + menaquinone
NAD+ + menaquinol
NADH + H+ + oxidized 2,6-dichloroindophenol
NAD+ + reduced 2,6-dichloroindophenol
-
-
-
?
NADH + H+ + ubiquinone-1
NAD+ + ubiquinol-1
NADH + H+ + ubiquinone-10
NAD+ + ubiquinol-10
NADH + menadione
NAD+ + menadiol
NADH + menadione
NAD+ + reduced menadione
-
-
-
-
?
NADH + menaquinone
NAD+ + menaquinol
-
-
-
-
?
NADH + methyl-p-benzoquinone
NAD+ + methyl-p-benzoquinol
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
NADH + paraquat
NAD+ + ?
-
the enzyme is a novel oxidation-reduction system participating in paraquat toxicity
-
?
NADH + plastoquinone
NAD+ + reduced plastoquinone
-
-
-
-
?
NADPH + H+ + 1,4-benzoquinone
NADP+ + 1,4-benzoquinol
NADPH + H+ + oxidized 2,6-dichlorophenolindophenol
NADP+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
NADPH + H+ + ubiquinone-1
NADP+ + ubiquinol-1
thionicotinamide-NADH + H+ + oxidized 2,6-dichlorophenolindophenol
thionicotinamide-NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium
-
-
-
-
?
additional information
?
-
2 ferricyanide + NADH

2 ferrocyanide + NAD+ + H+
-
-
-
-
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
-
-
-
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
-
-
-
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
-
-
-
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
-
-
-
?
2 ferricyanide + NADH
2 ferrocyanide + NAD+ + H+
-
-
-
?
2 ferricytochrome c + NADH

2 ferrocytochrome c + NAD+ + H+
-
-
-
-
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
-
-
-
-
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
-
-
-
-
?
2 ferricytochrome c + NADH
2 ferrocytochrome c + NAD+ + H+
-
-
-
-
?
3-acetylpyridine-deamino-NADH + 2,6-dichlorophenol indophenol

3-acetylpyridine-deamino-NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium
-
-
-
-
?
3-acetylpyridine-deamino-NADH + 2,6-dichlorophenol indophenol
3-acetylpyridine-deamino-NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium AR-I
-
-
-
-
?
3-acetylpyridine-NADH + 2,6-dichlorophenolindophenol

3-acetylpyridine-NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium
-
-
-
-
?
3-acetylpyridine-NADH + 2,6-dichlorophenolindophenol
3-acetylpyridine-NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium AR-I
-
-
-
-
?
NADH + 2,5-dimethoxy-1,4-benzoquinone

NAD+ + 2,5-dimethoxy-1,4-benzoquinol
-
-
-
-
?
NADH + 2,5-dimethoxy-1,4-benzoquinone
NAD+ + 2,5-dimethoxy-1,4-benzoquinol
2,5-dimethoxy-1,4-benzoquinone produced by Gleophyllum trabeum
-
?
NADH + 2,6-dimethoxy-1,4-benzoquinone

NAD+ + 2,6-dimethoxy-1,4-benzoquinol
-
-
?
NADH + 2,6-dimethoxy-1,4-benzoquinone
NAD+ + 2,6-dimethoxy-1,4-benzoquinol
-
-
-
-
?
NADH + 2-methyl-1,4-naphthoquinone

NAD+ + 2-methyl-1,4-naphthoquinol
-
-
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
-
-
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
halophilic bacterium
-
i.e. menadione, about 60% of the activity with 2,6-dichlorophenolindophenol
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
halophilic bacterium AR-I
-
i.e. menadione, about 60% of the activity with 2,6-dichlorophenolindophenol
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
-
-
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
-
-
-
-
?
NADH + 2-methyl-1,4-naphthoquinone
NAD+ + 2-methyl-1,4-naphthoquinol
-
-
-
-
?
NADH + 5-hydroxy-1,4-naphthoquinone

NAD+ + 5-hydroxy-1,4-naphthoquinol
halophilic bacterium
-
i.e. juglone, about 55% of the activity with 2,6-dichlorophenolindophenol
-
-
?
NADH + 5-hydroxy-1,4-naphthoquinone
NAD+ + 5-hydroxy-1,4-naphthoquinol
halophilic bacterium AR-I
-
i.e. juglone, about 55% of the activity with 2,6-dichlorophenolindophenol
-
-
?
NADH + benzoquinone

NAD+ + benzoquinol
-
-
-
?
NADH + benzoquinone
NAD+ + benzoquinol
-
-
-
-
?
NADH + benzoquinone
NAD+ + benzoquinol
-
ping-pong kinetics, two electron transfer mechanism
-
-
?
NADH + benzoquinone
NAD+ + benzoquinol
-
benzoquinone is the best acceptor
-
?
NADH + benzoquinone
NAD+ + benzoquinol
-
-
-
?
NADH + duroquinone

NAD+ + duroquinol
-
-
-
-
?
NADH + duroquinone
NAD+ + duroquinol
-
-
-
-
?
NADH + H+ + 1,4-benzoquinone

NAD+ + 1,4-benzoquinol
-
-
-
?
NADH + H+ + 1,4-benzoquinone
NAD+ + 1,4-benzoquinol
-
-
-
?
NADH + H+ + 1,4-naphthoquinone

NAD+ + 1,4-naphthoquinol
-
-
-
?
NADH + H+ + 1,4-naphthoquinone
NAD+ + 1,4-naphthoquinol
-
1,4-naphthoquinone is one of the best acceptors
-
?
NADH + H+ + 2,3-dimethyl naphthoquinone

NAD+ + 2,3-dimethyl naphthoquinol
-
-
-
-
?
NADH + H+ + 2,3-dimethyl naphthoquinone
NAD+ + 2,3-dimethyl naphthoquinol
-
-
-
-
?
NADH + H+ + clofazimine

NAD+ + reduced clofazimine
-
NDH-2 is the only respiratory chain oxidoreductase capable of reducing clofazimine
-
-
?
NADH + H+ + clofazimine
NAD+ + reduced clofazimine
-
NDH-2 is the only respiratory chain oxidoreductase capable of reducing clofazimine
-
-
?
NADH + H+ + clofazimine
NAD+ + reduced clofazimine
-
NDH-2 is the only respiratory chain oxidoreductase capable of reducing clofazimine
-
-
?
NADH + H+ + menaquinone

NAD+ + menaquinol
-
-
-
-
?
NADH + H+ + menaquinone
NAD+ + menaquinol
-
-
-
-
?
NADH + H+ + menaquinone
NAD+ + menaquinol
-
-
-
-
?
NADH + H+ + ubiquinone-1

NAD+ + ubiquinol-1
-
-
-
?
NADH + H+ + ubiquinone-1
NAD+ + ubiquinol-1
-
-
-
?
NADH + H+ + ubiquinone-10

NAD+ + ubiquinol-10
-
-
-
?
NADH + H+ + ubiquinone-10
NAD+ + ubiquinol-10
-
-
-
?
NADH + menadione

NAD+ + menadiol
-
-
-
?
NADH + menadione
NAD+ + menadiol
-
-
-
?
NADH + menadione
NAD+ + menadiol
-
menadione is a poor electron acceptor
-
?
NADH + menadione
NAD+ + menadiol
-
menadione is one of the best acceptors
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+

NAD+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
halophilic bacterium AR-I
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
-
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
specific for NADH
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
specific for NADH
-
-
?
NADH + oxidized 2,6-dichlorophenolindophenol + H+
NAD+ + reduced 2,6-dichlorophenolindophenol
-
-
-
?
NADPH + H+ + 1,4-benzoquinone

NADP+ + 1,4-benzoquinol
-
-
-
?
NADPH + H+ + 1,4-benzoquinone
NADP+ + 1,4-benzoquinol
-
-
-
?
NADPH + H+ + ubiquinone-1

NADP+ + ubiquinol-1
-
-
-
?
NADPH + H+ + ubiquinone-1
NADP+ + ubiquinol-1
-
-
-
?
additional information

?
-
-
no direct involvement of electron carriers in H+ (Na+) tranlocation
-
-
-
additional information
?
-
-
enzyme is involved in the respiratory chain
-
-
-
additional information
?
-
-
enzyme is involved in the respiratory chain
-
-
-
additional information
?
-
-
enzyme is most active toward naphtho- and benzoquinones, whereas ferricyanide and dichlorophenolindophenol are less efficient. Enzyme reacts with ubiquinone Q-l, but ubiquinones with a long side-chain such as Q-5 and Q-10 are virtually inactive as electron acceptors
-
-
-
additional information
?
-
the enzyme may function in quinone detoxification, it is also hypothesized that the fungus has recruited it to drive extracellular oxyradical production
-
-
-
additional information
?
-
-
activity is increased in the presence of 2,6-dimethoxy-1,4-benzoquinone and, to a lesser extent, vanillic acid. Expression is time-dependent and influenced by nitrogen levels
-
-
-
additional information
?
-
-
deamino-NADH does not serve as substrate
-
-
-
additional information
?
-
-
the enzyme can not utilize free flavins, cytochrome c or molecular oxygen as an electron acceptor
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-hydroxy-2-dodecyl-4(1H)-quinolone
-
-
1-hydroxy-2-methyl-3-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
1-hydroxy-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
1-hydroxy-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
1-hydroxy-3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
-
-
2,6-dichlorophenol indophenol
2-(2',4'-difluorobiphenyl-4-yl)-3-methylquinolin-4(1H)-one
-
-
2-(2'-fluorobiphenyl-4-yl)-3-methylquinolin-4(1H)-one
-
-
2-(3-[4-[2-(diethylnitroryl)ethoxy]benzyl]phenyl)-3-methylquinolin-4(1H)-one
-
-
2-(3-[4-[2-(diethylnitroryl)ethoxy]phenoxy]phenyl)-3-methylquinolin-4(1H)-one
-
-
2-(4-benzylphenyl)-3-methylquinolin-4(1H)-one
-
-
2-(4-bromophenyl)-3-methyl-1,8-naphthyridin-4(1H)-one
-
-
2-(4-hydroxyphenyl)quinolin-4(1H)-one
-
-
2-(4-methoxyphenyl)-3-methyl-1,8-naphthyridin-4(1H)-one
-
-
2-(4-methoxyphenyl)quinolin-4(1H)-one
-
-
2-(4-[4-[2-(diethylnitroryl)ethoxy]phenoxy]phenyl)-3-methylquinolin-4(1H)-one
-
-
2-(hydroxymethyl)-3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
-
-
2-methyl-3-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
2-methyl-3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
-
-
2-[3,5-difluoro-4'-(trifluoromethoxy)biphenyl-4-yl]-3-methylquinolin-4(1H)-one
-
-
2-[4-(4-chlorophenoxy)phenyl]-3-methylquinolin-4(1H)-one
-
-
2-[4-(4-fluorobenzyl)phenyl]-3-methylquinolin-4(1H)-one
-
-
2-[4-(4-methoxybenzyl)phenyl]-3-methylquinolin-4(1H)-one
-
-
2-[4-(trifluoromethoxy)phenyl]quinolin-4(1H)-one
-
-
2-[4-(trifluoromethyl)phenyl]quinolin-4(1H)-one
-
-
2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
2-[6-(2,4-difluorophenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
-
-
2-[6-(3-fluorophenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
-
-
2-[6-(3-hydroxyphenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
-
-
2-[6-(3-methoxyphenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
-
-
2-[6-(4-hydroxyphenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
-
-
3-(hydroxymethyl)-2-[4'-(trifluoromethoxy)biphenyl-4-yl]quinolin-4(1H)-one
-
-
3-(hydroxymethyl)-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-chloro-2-(4-methoxyphenyl)quinolin-4(1H)-one
-
-
3-chloro-2-[4-(trifluoromethoxy)phenyl]quinolin-4(1H)-one
-
-
3-chloro-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
3-methoxy-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-methyl-2-[2'-(trifluoromethyl)biphenyl-4-yl]quinolin-4(1H)-one
-
-
3-methyl-2-[3-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
3-methyl-2-[4'-(trifluoromethoxy)biphenyl-4-yl]quinolin-4(1H)-one
-
-
3-methyl-2-[4-(trifluoromethoxy)phenyl]-1,8-naphthyridin-4(1H)-one
-
-
3-methyl-2-[4-(trifluoromethoxy)phenyl]quinolin-4(1H)-one
-
-
3-methyl-2-[4-(trifluoromethyl)phenyl]-1,8-naphthyridin-4(1H)-one
-
-
3-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-4(1H)-one
-
-
3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-1,8-naphthyridin-4(1H)-one
-
-
3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-6-(trifluoromethyl)quinolin-4(1H)-one
-
-
3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
-
-
3-methyl-2-[6-[3-(trifluoromethyl)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]-6-(trifluoromethyl)quinolin-4(1H)-one
-
-
3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]-7-(trifluoromethyl)quinolin-4(1H)-one
-
-
3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-methyl-2-[6-[4-(trifluoromethyl)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-methyl-6-(methylsulfonyl)-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-methyl-7-(trifluoromethoxy)-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
3-pyridine aldehyde NADH
halophilic bacterium
-
competitive with respect to NADH
3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
-
-
5-(N-ethyl-N-isopropyl) amiloride
5-(N-methyl-N-isobutyl)amiloride
5-hydroxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
5-methoxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
6,7-difluoro-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
6,7-difluoro-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
6,7-difluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
6,8-difluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
6-chloro-1-hydroxy-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
6-chloro-2-[3-(4-fluorobenzyl)phenyl]-3-methylquinolin-4(1H)-one
-
-
6-chloro-3-(hydroxymethyl)-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
6-chloro-3-methyl-2-[3-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
6-chloro-3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
-
-
6-chloro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
6-chloro-7-fluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
6-fluoro-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
6-fluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
6-hydroxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
7-chloro-3-methyl-2-(4-(4-(trifluoromethoxy)benzyl)phenyl)quinolin-4(1H)-one
-
i.e. CK-2-68, shows potent in vivo antimalarial activity after oral administration, is selective for PfNDH2 over other respiratory enzymes, and demonstrates low cytotoxicity and high metabolic stability in the presence of human liver microsomes
7-chloro-3-methyl-2-[3-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
-
-
7-chloro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
7-chloro-6-fluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
7-hydroxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
7-methoxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
8-methoxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
-
-
adenine
-
3 mM, 60% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH
ADP
-
10 mM, 90% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH, competitive
ATP
-
10 mM, 50% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH, competitive
cAMP
-
10 mM, 76% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH
Cibacron blue
-
competitive
deoxyadenosine
-
10 mM, 32% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH
deoxyAMP
-
10 mM, 41% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH
diphenylene iodonium chloride
-
-
ethyl 2-(4'-chlorobiphenyl-4-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
-
-
ethyl 2-methyl-3-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4-yl carbonate
-
-
ethyl 3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4-yl carbonate
-
-
ethyl 3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4-yl carbonate
-
-
ethyl 4-oxo-2-[4'-(trifluoromethoxy)biphenyl-4-yl]-1,4-dihydroquinoline-3-carboxylate
-
-
ethyl 4-oxo-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]-1,4-dihydroquinoline-3-carboxylate
-
-
flavone
-
IC50: 0.158 mM, weak inhibitor
HgCl2
-
completely inhibits at 0.1 mM
hydroxy-2-dodecyl-4-(1H)-quinolone
-
-
methyl 4-oxo-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-1,4-dihydroquinoline-3-carboxylate
-
-
methyl 6-chloro-4-oxo-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-1,4-dihydroquinoline-3-carboxylate
-
-
N,N'-dicyclohexylcarbodiimide
-
2 mM, 79% inhibition of wild-type enzyme after 4 h at room temperature, 74% inhibition of mutant enzyme K46A, 77% inhibition of mutant enzyme E51A, 71% inhibition of mutant enzyme D79A, 76% inhibitiuon of mutant enzyme D79N, 50% inhibition of mutant enzyme E81A, 30% inhibition of mutant enzyme E81Q
p-chloromercuribenzoate
-
completely inhibits at 0.1 mM
p-hydroxymercuribenzoate
-
less than 40% inhibition at 0.001 mM, 100% inhibition at 0.5 mM
p-Hydroxymercuriphenyl sulfonate
-
2 mM, 20% inhibition of activity with ferricyanide
phenothiazine
-
1 mM, complete inhibition
phosphate
-
no deactivation
Thenoyltrifluoroacetone
-
-
2,4-dinitrophenol

-
not inhibitory
2,4-dinitrophenol
-
52% inhibition at 0.16 mM and 100% inhibition at 0.33 mM
2,6-dichlorophenol indophenol

halophilic bacterium
-
above 0.07 mM
2,6-dichlorophenol indophenol
halophilic bacterium
-
product inhibitor
5-(N-ethyl-N-isopropyl) amiloride

-
IC50: above 0.001 mM, inhibition at 0.1 mM is 30% or less
5-(N-ethyl-N-isopropyl) amiloride
-
IC50: 0.017 mM
5-(N-ethyl-N-isopropyl) amiloride
-
IC50: above 0.1 mM
5-(N-ethyl-N-isopropyl) amiloride
-
IC50: 0.063 mM
5-(N-methyl-N-isobutyl)amiloride

-
IC50: about 0.001 mM
5-(N-methyl-N-isobutyl)amiloride
-
IC50: 0.017 mM
5-(N-methyl-N-isobutyl)amiloride
-
0.1 mM, inhibition is 30% or less, enzyme NDH-2; IC50: 0.045 mM
5-(N-methyl-N-isobutyl)amiloride
-
IC50: 0.02 mM
AMP

-
-
AMP
-
10 mM, 98% inhibition in the reaction with 0.04 mM 2,6-dichlorophenolindophenol and 0.032 mM NADH, competitive
AMP
halophilic bacterium
-
competitive inhibition of NADH oxidation
AMP
-
at high concentrations
benzamil

-
IC50: about 0.001 mM
benzamil
-
IC50: 0.005 mM
benzamil
-
0.1 mM, inhibition is 30% or less, enzyme NDH-2; IC50: 0.045 mM
benzamil
-
IC50: 0.042 mM
chlorpromazine

-
-
dicoumarol

-
competitive with NADH
dicoumarol
-
3 microM, 85% inhibition
dicoumarol
-
at high concentrations
NAD+

-
effectively competitive
NAD+
halophilic bacterium
-
competitive inhibition of NADH oxidation
NAD+
halophilic bacterium
-
product inhibitor, competitive with NADH, non-competitive with 2,6-dichlorophenolindophenol
NADH

-
-
rotenone

-
-
rotenone
-
not inhibitory
Trifluoperazine

-
-
additional information

-
no inhibition by 0.1 mM 5-(N-ethyl-N-isopropyl) amiloride, enzyme NDH-2
-
additional information
-
no inhibition by 1 mM ZnSO4, MgSO4, CuSO4, MnSO4, EDTA or NaN3
-
additional information
-
no inhibition by rotenone, piericidin and pyridaben
-
additional information
-
activation by monovalent cations is due to increase of affinity of the enzyme for substrates
-
additional information
-
inhibitor screening using hydroxy-2-dodecyl-4-(1H)-quinolone as template, overview. Selection of 2-bisaryl 3-methyl quinolones
-
additional information
-
identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase, PfNDH2, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00067
1-hydroxy-2-methyl-3-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000403
1-hydroxy-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000217
1-hydroxy-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000566
1-hydroxy-3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000213
2-(2',4'-difluorobiphenyl-4-yl)-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000471
2-(2'-fluorobiphenyl-4-yl)-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000355
2-(3-[4-[2-(diethylnitroryl)ethoxy]benzyl]phenyl)-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000719
2-(3-[4-[2-(diethylnitroryl)ethoxy]phenoxy]phenyl)-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000416
2-(4-benzylphenyl)-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
2-(4-bromophenyl)-3-methyl-1,8-naphthyridin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.001
2-(4-hydroxyphenyl)quinolin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publicationabove
0.001
2-(4-methoxyphenyl)-3-methyl-1,8-naphthyridin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.001
2-(4-methoxyphenyl)quinolin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.001
2-(4-[4-[2-(diethylnitroryl)ethoxy]phenoxy]phenyl)-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.000091
2-(hydroxymethyl)-3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000036
2-methyl-3-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00001
2-methyl-3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00094
2-[3,5-difluoro-4'-(trifluoromethoxy)biphenyl-4-yl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000797
2-[4-(4-chlorophenoxy)phenyl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000273
2-[4-(4-fluorobenzyl)phenyl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000577
2-[4-(4-methoxybenzyl)phenyl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000675
2-[4-(trifluoromethoxy)phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000579
2-[4-(trifluoromethyl)phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000251
2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000219
2-[6-(2,4-difluorophenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000151
2-[6-(3-fluorophenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
2-[6-(3-hydroxyphenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000556
2-[6-(3-methoxyphenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
2-[6-(4-hydroxyphenyl)pyridin-3-yl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000162
3-(hydroxymethyl)-2-[4'-(trifluoromethoxy)biphenyl-4-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000103
3-(hydroxymethyl)-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00056
3-chloro-2-(4-methoxyphenyl)quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000513
3-chloro-2-[4-(trifluoromethoxy)phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000328
3-chloro-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000093
3-methoxy-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000096
3-methyl-2-[2'-(trifluoromethyl)biphenyl-4-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000065
3-methyl-2-[3-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000059
3-methyl-2-[4'-(trifluoromethoxy)biphenyl-4-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
3-methyl-2-[4-(trifluoromethoxy)phenyl]-1,8-naphthyridin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.001
3-methyl-2-[4-(trifluoromethoxy)phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.001
3-methyl-2-[4-(trifluoromethyl)phenyl]-1,8-naphthyridin-4(1H)-one
Plasmodium falciparum
-
above, pH and temperature not specified in the publication
0.000752
3-methyl-2-[4-(trifluoromethyl)phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00188
3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-1,8-naphthyridin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000178
3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-6-(trifluoromethyl)quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000122
3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000092
3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000109
3-methyl-2-[6-[3-(trifluoromethyl)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]-6-(trifluoromethyl)quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]-7-(trifluoromethyl)quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000054
3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000102
3-methyl-2-[6-[4-(trifluoromethyl)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
3-methyl-6-(methylsulfonyl)-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
3-methyl-7-(trifluoromethoxy)-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000797
3-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001 - 0.1
5-(N-ethyl-N-isopropyl) amiloride
0.001 - 0.045
5-(N-methyl-N-isobutyl)amiloride
0.001
5-hydroxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
5-methoxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000626
6,7-difluoro-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000207
6,7-difluoro-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000344
6,7-difluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000286
6,8-difluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
6-chloro-1-hydroxy-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000552
6-chloro-2-[3-(4-fluorobenzyl)phenyl]-3-methylquinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00033
6-chloro-3-(hydroxymethyl)-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000094
6-chloro-3-methyl-2-[3-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000274
6-chloro-3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000373
6-chloro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00039
6-chloro-7-fluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000191
6-fluoro-3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000075
6-fluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000202
6-hydroxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000031
7-chloro-3-methyl-2-[3-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000298
7-chloro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00039
7-chloro-6-fluoro-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.00028
7-hydroxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
7-methoxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.001
8-methoxy-3-methyl-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]quinolin-4(1H)-one
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.017 - 0.0275
chlorpromazine
0.00022
ethyl 2-(4'-chlorobiphenyl-4-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000224
ethyl 2-methyl-3-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4-yl carbonate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.0000068
ethyl 3-methyl-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]quinolin-4-yl carbonate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000406
ethyl 3-methyl-2-[4-[4-(trifluoromethoxy)phenoxy]phenyl]quinolin-4-yl carbonate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000347
ethyl 4-oxo-2-[4'-(trifluoromethoxy)biphenyl-4-yl]-1,4-dihydroquinoline-3-carboxylate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000987
ethyl 4-oxo-2-[6-[4-(trifluoromethoxy)phenyl]pyridin-3-yl]-1,4-dihydroquinoline-3-carboxylate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.158
flavone
Mycobacterium tuberculosis
-
IC50: 0.158 mM, weak inhibitor
0.0014
methyl 4-oxo-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-1,4-dihydroquinoline-3-carboxylate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.000092
methyl 6-chloro-4-oxo-2-[4-[4-(trifluoromethoxy)benzyl]phenyl]-1,4-dihydroquinoline-3-carboxylate
Plasmodium falciparum
-
pH and temperature not specified in the publication
0.0079 - 0.0135
thioridazine
0.0265
Trifluoperazine
Staphylococcus aureus
-
isoform NdhC, pH 7.5, 37°C
0.001
5-(N-ethyl-N-isopropyl) amiloride

Bacillus subtilis
-
IC50: above 0.001 mM, inhibition at 0.1 mM is 30% or less
0.017
5-(N-ethyl-N-isopropyl) amiloride
Bos taurus
-
IC50: 0.017 mM
0.063
5-(N-ethyl-N-isopropyl) amiloride
Paracoccus denitrificans
-
IC50: 0.063 mM
0.1
5-(N-ethyl-N-isopropyl) amiloride
Escherichia coli
-
IC50: above 0.1 mM
0.001
5-(N-methyl-N-isobutyl)amiloride

Bacillus subtilis
-
IC50: about 0.001 mM
0.017
5-(N-methyl-N-isobutyl)amiloride
Bos taurus
-
IC50: 0.017 mM
0.02
5-(N-methyl-N-isobutyl)amiloride
Paracoccus denitrificans
-
IC50: 0.02 mM
0.045
5-(N-methyl-N-isobutyl)amiloride
Escherichia coli
-
IC50: 0.045 mM
0.001
benzamil

Bacillus subtilis
-
IC50: about 0.001 mM
0.005
benzamil
Bos taurus
-
IC50: 0.005 mM
0.042
benzamil
Paracoccus denitrificans
-
IC50: 0.042 mM
0.045
benzamil
Escherichia coli
-
IC50: 0.045 mM
0.017
chlorpromazine

Staphylococcus aureus
-
isoform NdhC, pH 7.5, 37°C
0.0275
chlorpromazine
Staphylococcus aureus
-
isoform NdhF, pH 7.5, 37°C
0.0079
thioridazine

Staphylococcus aureus
-
isoform NdhC, pH 7.5, 37°C
0.0135
thioridazine
Staphylococcus aureus
-
isoform NdhF, pH 7.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D135A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 44% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 44% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 80% of wild-type activity
D135E
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 87% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 91% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 93% of wild-type activity
D135N
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 78% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 78% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 86% of wild-type activity
D79A
-
mutation partially suppresses deamino-NADH-quinone reductase activity. In terms of immunochemical and NADH dehydrogenase activity-staining analysis the mutant is similar to the wild-type enzyme suggesting that the mutation does not significantly affect the assembly of the peripheral subunits in situ
D79N
-
mutation partially suppresses deamino-NADH-quinone reductase activity. In terms of immunochemical and NADH dehydrogenase activity-staining analysis the mutant is similar to the wild-type enzyme suggesting that the mutation does not significantly affect the assembly of the peripheral subunits in situ
D79N/E81Q
-
almost complete loss of energy-transducing activities, does not display any loss of deamino-NADH-K3Fe(CN)6 reductase activity
D84A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 83% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 94% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 92% of wild-type activity
D84N
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 89% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 83% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 97% of wild-type activity
E144A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 2% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 10% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 103% of wild-type activity
E144D
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 89% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 97% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 100% of wild-type activity
E144Q
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 2% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 2% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 98% of wild-type activity
E51A
-
mutation partially suppresses deamino-NADH-quinone reductase activity. In terms of immunochemical and NADH dehydrogenase activity-staining analysis the mutant is similar to the wild-type enzyme suggesting that the mutation does not significantly affect the assembly of the peripheral subunits in situ
E81A
-
mutation partially suppresses deamino-NADH-quinone reductase activity. In terms of immunochemical and NADH dehydrogenase activity-staining analysis the mutant is similar to the wild-type enzyme suggesting that the mutation does not significantly affect the assembly of the peripheral subunits in situ
E81Q
-
mutation partially suppresses deamino-NADH-quinone reductase activity
H196A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 79% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 87% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 99% of wild-type activity
H241A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 88% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 87% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 90% of wild-type activity
H322A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 100% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 94% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 99% of wild-type activity
H348A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 92% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 98% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 100% of wild-type activity
K234A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 8% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 16% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 91% of wild-type activity
K265A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 35% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 30% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 96% of wild-type activity
K46A
-
mutation scarcely inhibits deamino-NADH-quinone reductase activity. In terms of immunochemical and NADH dehydrogenase activity-staining analysis the mutant is similar to the wild-type enzyme suggesting that the mutation does not significantly affect the assembly of the peripheral subunits in situ
P245A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 102% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 99% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 100% of wild-type activity
R273A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 92% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 97% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 105% of wild-type activity
R365A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 87% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 85% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 92% of wild-type activity
R369H
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 63% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 68% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 94% of wild-type activity
W243A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 103% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 98% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 97% of wild-type activity
W243Y
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 104% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 104% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 108% of wild-type activity
Y435A
-
NuoM-subunit mutant, deamino-NADH oxidase activity is 99% of wild-type activity, deamino-NADH/2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone reductase activity is 102% of wild-type activity, deamino-NADH/K3Fe(CN)6 reductase activity is 94% of wild-type activity
A49C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
E50C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
G84C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
H168C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
M2C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
N25C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
R142C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
S114C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
W182C
-
Escherichia coli cells expression the Nqo10 mutant protein grow normally. The expression level and the subcellular distribution of the mutated MBP-fused Nqo10 subunit shows no substantial difference from those of the wild-type
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Nakamaru-Ogiso, E.; Yano, T.; Ohnishi, T.; Yagi, T.
Characterization of the iron-sulfur cluster coordinated by a cysteine cluster motif (CXXCXXXCX27C) in the Nqo3 subunit in the proton-translocating NADH-quinone oxidoreductase (NDH-1) of Thermus thermophilus HB-8
J. Biol. Chem.
277
1680-1688
2002
Thermus thermophilus
brenda
Hochstein, L.I.; Dalton, B.P.
Studies of a halophilic NADH dehydrogenase. I. Purification and properties of the enzyme
Biochim. Biophys. Acta
302
216-228
1973
halophilic bacterium, halophilic bacterium AR-I
brenda
Ohshima, T.; Ohshima, M.; Drews, G.
Purification and partial characterization of the soluble NADH dehydrogenase from a phototrophic bacterium Rhodopseudomonas capsulata
Z. Naturforsch. C
39
68-72
1984
Rhodobacter capsulatus, Rhodobacter capsulatus 37b4
-
brenda
Ohshima, T.; Drews, G.
Isolation and partial characterization of the membrane-bound NADH dehydrogenase from the phototrophic bacterium Rhodopseudomonas capsulata
Z. Naturforsch. C
36
400-406
1981
Rhodobacter capsulatus
-
brenda
Hisae, N.; Aizawa, K.; Koyama, N.; Sekiguchi, T.; Nosoh, Y.
Purification and properties of NADH dehydrogenase from an alkalophilic Bacillus
Biochim. Biophys. Acta
743
232-238
1983
Bacillus sp.
-
brenda
Imagawa, T.; Nakamura, T.
Properties and kinetics of salt activation of a membrane-bound NADH dehydrogenase from a marine bacterium Photobacterium phosphoreum
J. Biochem.
84
547-557
1978
Photobacterium phosphoreum
brenda
Hermans, L.
Purification of mitochondrial NADH dehydrogenase from Drosophila hydei and comparison with the heat-shock polypeptides
Biochim. Biophys. Acta
567
125-134
1979
Drosophila hydei
brenda
Dancey, G.F.; Shapiro, B.M.
Specific phospholipid requirement for activity of the purified respiratory chain NADH dehydrogenase of Escherichia coli
Biochim. Biophys. Acta
487
368-377
1977
Escherichia coli
brenda
Hochstein, L.I.
Studies of a halophilic NADH dehydrogenase. II. Kinetic properties of the enzyme in relation to salt activation
Biochim. Biophys. Acta
403
58-66
1975
halophilic bacterium
brenda
Schwartz, A.C.; Krause, A.E.
Partial purification and properties of NADH dehydrogenase from Propionibacterium shermanii
Z. Allg. Mikrobiol.
15
99-110
1975
Propionibacterium freudenreichii subsp. shermanii
-
brenda
Dancey, G.F.; Levine, A.E.; Shapiro, B.M.
The NADH dehydrogenase of the respiratory chain of Escherichia coli. I. Properties of the membrane-bound enzyme, its solubilization, and purification to near homogeneity
J. Biol. Chem.
251
5911-5920
1976
Escherichia coli
brenda
Dancey, G.F.; Shapiro, B.M.
The NADH dehydrogenase of the respiratory chain of Escherichia coli. II. Kinetics of the purified enzyme and the effects of antibodies elicited against it on membrane-bound and free enzyme
J. Biol. Chem.
251
5921-5928
1976
Escherichia coli
brenda
Koli, A.K.; Yearby, C.; Scott, W.; Donaldson, K.O.
Purification and properties of three separate menadione reductases from hog liver
J. Biol. Chem.
244
621-629
1969
Sus scrofa
brenda
Sandmann, G.; Malkin, R.
NADH and NADPH dehydrogenases from the blue-green alga, Aphanocapsa
Arch. Microbiol.
136
49-53
1983
Aphanocapsa
-
brenda
Frei, B.; Winterhalter, K.H.; Richter, C.
Menadione-(2-methyl-1,4-naphtoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria
Biochemistry
25
4438-4443
1986
Rattus norvegicus
brenda
Kanbe, C.; Uchida, K.
NADH dehydrogenase activity of Pediococcus halophilus as a factor determining its reducing force
Agric. Biol. Chem.
51
507-514
1987
Tetragenococcus halophilus
brenda
Shimada, H.; Hirai, K.; Simamura, E.; Pan, J.
Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers
Arch. Biochem. Biophys.
351
75-81
1998
Rattus norvegicus
brenda
Jensen, K.A.; Ryan, Z.C.; Vanden Wymelenberg, A.; Cullen, D.; Hammel, K.E.
An NADH:quinone oxidoreductase active during biodegradation by the brown-rot basidiomycete Gloeophyllum trabeum
Appl. Environ. Microbiol.
68
2699-2703
2002
Gloeophyllum trabeum (Q8X172)
brenda
Hayashi, M.; Hasegawa, K.; Oguni, Y.; Unemoto, T.
Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli
Biochim. Biophys. Acta
1035
230-236
1990
Escherichia coli
brenda
Kao, M.C.; Di Bernardo, S.; Matsuno-Yagi, A.; Yagi, T.
Characterization of the membrane domain Nqo11 subunit of the proton-translocating NADH-quinone oxidoreductase of Paracoccus denitrificans
Biochemistry
41
4377-4384
2002
Paracoccus denitrificans
brenda
Kao, M.C.; Di Bernardo, S.; Matsuno-Yagi, A.; Yagi, T.
Characterization and topology of the membrane domain Nqo10 subunit of the proton-translocating NADH-quinone oxidoreductase of Paracoccus denitrificans
Biochemistry
42
4534-4543
2003
Paracoccus denitrificans
brenda
Mathiesen, C.; Hagerhall, C.
Transmembrane topology of the NuoL, M and N subunits of NADH:quinone oxidoreductase and their homologues among membrane-bound hydrogenases and bona fide antiporters
Biochim. Biophys. Acta
1556
121-132
2002
Rhodobacter capsulatus (P50939), Rhodobacter capsulatus (P50973), Rhodobacter capsulatus (P50974)
brenda
Nakamaru-Ogiso, E.; Seo, B.B.; Yagi, T.; Matsuno-Yagi, A.
Amiloride inhibition of the proton-translocating NADH-quinone oxidoreductase of mammals and bacteria
FEBS Lett.
549
43-46
2003
Bacillus subtilis, Bos taurus, Escherichia coli, Paracoccus denitrificans
brenda
Qi, W.; Jellison, J.
Induction and catalytic properties of an intracellular NADH-dependent 1,4-benzoquinone reductase from the brown-rot basidiomycete Gloeophyllum trabeum
Int. Biodeter. Biodegrad.
54
53-60
2004
Gloeophyllum trabeum
-
brenda
Choi, D.W.; Kunz, R.C.; Boyd, E.S.; Semrau, J.D.; Antholine, W.E.; Han, J.I.; Zahn, J.A.; Boyd, J.M.; de la Mora, A.M.; DiSpirito, A.A.
The membrane-associated methane monooxygenase (pMMO) and pMMO-NADH:quinone oxidoreductase complex from Methylococcus capsulatus Bath
J. Bacteriol.
185
5755-5764
2003
Methylococcus capsulatus, Methylococcus capsulatus Bath
brenda
Kao, M.C.; Di Bernardo, S.; Perego, M.; Nakamaru-Ogiso, E.; Matsuno-Yagi, A.; Yagi, T.
Functional roles of four conserved charged residues in the membrane domain subunit NuoA of the proton-translocating NADH-quinone oxidoreductase from Escherichia coli
J. Biol. Chem.
279
32360-32366
2004
Escherichia coli
brenda
Uyemura, S.A.; Luo, S.; Vieira, M.; Moreno, S.N.; Docampo, R.
Oxidative phosphorylation and rotenone-insensitive malate- and NADH-quinone oxidoreductases in Plasmodium yoelii yoelii mitochondria in situ
J. Biol. Chem.
279
385-393
2004
Plasmodium yoelii yoelii, Plasmodium yoelii yoelii (Q7RJ45)
brenda
Nakamaru-Ogiso, E.; Yano, T.; Yagi, T.; Ohnishi, T.
Characterization of the iron-sulfur cluster N7 (N1c) in the subunit NuoG of the proton-translocating NADH-quinone oxidoreductase from Escherichia coli
J. Biol. Chem.
280
301-307
2005
Escherichia coli
brenda
Zhang, P.; Battchikova, N.; Paakkarinen, V.; Katoh, H.; Iwai, M.; Ikeuchi, M.; Pakrasi, H.B.; Ogawa, T.; Aro, E.M.
Isolation, subunit composition and interaction of the NDH-1 complexes from Thermosynechococcus elongatus BP-1
Biochem. J.
390
513-520
2005
Thermosynechococcus elongatus
brenda
Nantapong, N.; Otofuji, A.; Migita, C.T.; Adachi, O.; Toyama, H.; Matsushita, K.
Electron transfer ability from NADH to menaquinone and from NADPH to oxygen of type II NADH dehydrogenase of Corynebacterium glutamicum
Biosci. Biotechnol. Biochem.
69
149-159
2005
Corynebacterium glutamicum
brenda
Bernard, L.; Desplats, C.; Mus, F.; Cuine, S.; Cournac, L.; Peltier, G.
Agrobacterium tumefaciens type II NADH dehydrogenase. Characterization and interactions with bacterial and thylakoid membranes
FEBS J.
273
3625-3637
2006
Agrobacterium tumefaciens, Agrobacterium tumefaciens C58
brenda
Weinstein, E.A.; Yano, T.; Li, L.; Avarbock, D.; Avarbock, A.; Helm, D.; McColm, A.A.; Duncan, K.; Lonsdale, J.T.; Rubin, H.
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Proc. Natl. Acad. Sci. USA
102
4548-4553
2005
Mycobacterium tuberculosis
brenda
Andrade, S.L.; Patridge, E.V.; Ferry, J.G.; Einsle, O.
Crystal structure of the NADH:quinone oxidoreductase WrbA from Escherichia coli
J. Bacteriol.
189
9101-9107
2007
Escherichia coli
brenda
Torres-Bacete, J.; Nakamaru-Ogiso, E.; Matsuno-Yagi, A.; Yagi, T.
Characterization of the NuoM (ND4) subunit in Escherichia coli NDH-1: conserved charged residues essential for energy-coupled activities
J. Biol. Chem.
282
36914-36922
2007
Escherichia coli
brenda
Fisher, N.; Warman, A.J.; Ward, S.A.; Biagini, G.A.
Type II NADH:quinone oxidoreductases of Plasmodium falciparum and Mycobacterium tuberculosis kinetic and high-throughput assays
Methods Enzymol.
456
303-320
2009
Mycobacterium tuberculosis
brenda
Yano, T.; Kassovska-Bratinova, S.; Teh, J.S.; Winkler, J.; Sullivan, K.; Isaacs, A.; Schechter, N.M.; Rubin, H.
Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: A pathway for the generation of bactericidal levels of reactive oxygen species
J. Biol. Chem.
286
10276-10287
2011
Escherichia coli, Mycobacterium smegmatis, Mycobacterium tuberculosis
brenda
Unemoto, T.; Shimada, H.; Hayashi, M.
Chemical structures critical for the induction of FMN-dependent NADH-quinone reductase in Escherichia coli
Biochim. Biophys. Acta
1099
170-174
1992
Escherichia coli
brenda
Pidathala, C.; Amewu, R.; Pacorel, B.; Nixon, G.L.; Gibbons, P.; Hong, W.D.; Leung, S.C.; Berry, N.G.; Sharma, R.; Stocks, P.A.; Srivastava, A.; Shone, A.E.; Charoensutthivarakul, S.; Taylor, L.; Berger, O.; Mbekeani, A.; Hill, A.; Fisher, N.E.; Warman, A.J.; Biagini, G.A.; Ward, S.A.; ONeill, P.M.
Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)
J. Med. Chem.
55
1831-1843
2012
Plasmodium falciparum
brenda
Leung, S.C.; Gibbons, P.; Amewu, R.; Nixon, G.L.; Pidathala, C.; Hong, W.D.; Pacorel, B.; Berry, N.G.; Sharma, R.; Stocks, P.A.; Srivastava, A.; Shone, A.E.; Charoensutthivarakul, S.; Taylor, L.; Berger, O.; Mbekeani, A.; Hill, A.; Fisher, N.E.; Warman, A.J.; Biagini, G.A.; Ward, S.A.; ONeill, P.M.
Identification, design and biological evaluation of heterocyclic quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2)
J. Med. Chem.
55
1844-1857
2012
Plasmodium falciparum
brenda
Ullmann, E.; Tan, T.C.; Gundinger, T.; Herwig, C.; Divne, C.; Spadiut, O.
A novel cytosolic NADH:quinone oxidoreductase from Methanothermobacter marburgensis
Biosci. Rep.
34; FEHLT
0000
2014
Methanothermobacter marburgensis (D9PVS9), Methanothermobacter marburgensis DSM 2133 (D9PVS9)
brenda
Rosario, A.L.; Sena, F.V.; Batista, A.P.; Oliveira, T.F.; Athayde, D.; Pereira, M.M.; Brito, J.A.; Archer, M.
Expression, purification, crystallization and preliminary X-ray diffraction analysis of a type II NADH:quinone oxidoreductase from the human pathogen Staphylococcus aureus
Acta Crystallogr. Sect. F
71
477-482
2015
Staphylococcus aureus
brenda
Schurig-Briccio, L.A.; Yano, T.; Rubin, H.; Gennis, R.B.
Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines
Biochim. Biophys. Acta
1837
954-963
2014
Staphylococcus aureus, Staphylococcus aureus bovine RF122
brenda